DalsnaFinance › Analyst accuracy › Piper Sandler › AMGN target
Amgen (AMGN) Gets Price Target Cut at Piper Sandler Despite Long-Term Growth Optimism
On May 14, Piper Sandler lowered its price recommendation on Amgen Inc. (NASDAQ:AMGN) to $427 from $432.
A fact about what Piper Sandler published, as reported by Yahoo Finance, not a recommendation from Dalsna Finance; Piper Sandler is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.